A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : E/S

Search Conditions:
Search Keyword : E/S
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: E/S
Appearance Frequency: 222 time(s)
Long forms: 29

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
excretory/secretory
(130 times)
Parasitology
(88 times)
ELISA (17 times)
p.i (5 times)
CE (3 times)
1984 A collaborative study on larval excretory/secretory antigens of Toxocara canis for the immunodiagnosis of human toxocariasis with ELISA.
enzyme/substrate
(19 times)
Biotechnology
(6 times)
ACE (4 times)
DH (3 times)
DPPH (2 times)
1996 Enzymic control of collagen fibril shape.
ezetimibe/simvastatin
(16 times)
Metabolism
(7 times)
LDL-C (6 times)
DM (4 times)
hs-CRP (3 times)
2007 Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
excretion/secretion
(10 times)
Parasitology
(7 times)
CB4 (1 time)
FCM (1 time)
HL (1 time)
1991 Trichinella spiralis: antigenic epitopes from the stichocytes detected in the hypertrophic nuclei and cytoplasm of the parasitized muscle fibre (nurse cell) of the host.
excreted/secreted
(9 times)
Parasitology
(6 times)
CF (1 time)
DCs (1 time)
EVs (1 time)
1993 Biochemical characterisation of Trichinella spiralis and T. pseudospiralis stichocyte antigens.
excretory/secretory antigens
(4 times)
Parasitology
(2 times)
WB (2 times)
ELISA (1 time)
IMAC (1 time)
2002 Identification of toxocara canis antigens by Western blot in experimentally infected rabbits.
electrolyte/sulfur
(3 times)
Chemistry
(1 time)
LiPSs (1 time)
MoP (1 time)
2018 Electrocatalysis in Lithium Sulfur Batteries under Lean Electrolyte Conditions.
ELISA
(3 times)
Parasitology
(2 times)
ELISASA (1 time)
p.i (1 time)
PT (1 time)
1997 Feline heartworm (Dirofilaria immitis) infection: detection of specific IgG for the diagnosis of occult infections.
enzyme-to-substrate
(3 times)
Nutritional Sciences
(1 time)
DPPH (2 times)
PLHs (1 time)
PVMGA (1 time)
2014 Novel antioxidative peptides from the protein hydrolysate of oysters (Crassostrea talienwhanensis).
10  epithelium-stroma
(3 times)
Urology
(2 times)
BPH (1 time)
FFKC (1 time)
KC (1 time)
1996 Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia.
11  excretory/secretory products
(3 times)
Parasitology
(2 times)
BMDM (1 time)
MR (1 time)
PHI (1 time)
1994 Experimental immunization of ponies with Strongylus vulgaris radiation-attenuated larvae or crude soluble somatic extracts from larval or adult stages.
12  exploration/selection
(2 times)
Medical Informatics
(2 times)
ESE (2 times)
HMRF (1 time)
ICE (1 time)
2005 A stochastic method for Bayesian estimation of hidden Markov random field models with application to a color model.
13  cost-effectiveness of ezetimibe plus simvastatin
(1 time)
Heart Diseases
(1 time)
QALY (1 time)
2011 Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia.
14  E and S
(1 time)
Pulmonary Medicine
(1 time)
EBC (1 time)
NPS (1 time)
RT-PCR (1 time)
2020 Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19).
15  Early S-phase
(1 time)
Molecular Biology
(1 time)
CP (1 time)
L/S (1 time)
PCC-SCD (1 time)
1989 Evidence for chromosomal replicons as units of sister chromatid exchanges.
16  effects of combination therapy with ezetimibe and statins
(1 time)
Biochemistry
(1 time)
HDL (1 time)
LDL-C (1 time)
MD (1 time)
2020 Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature.
17  effects of Emodin combined with silver nanoparticles
(1 time)
Pharmacology
(1 time)
BALF (1 time)
CLP (1 time)
LDH (1 time)
2016 Emodin Combined with Nanosilver Inhibited Sepsis by Anti-inflammatory Protection.
18  effusion/serum
(1 time)
Biochemistry
(1 time)
--- 1998 Diagnostic value of ferritin in the differential diagnosis of malignant effusions.
19  EPS beads to dry clay
(1 time)
EPS (1 time)
UU (1 time)
2019 Physical and Mechanical Properties of a Bulk Lightweight Concrete with Expanded Polystyrene (EPS) Beads and Soft Marine Clay.
20  EPSP/spike
(1 time)
Neurology
(1 time)
LTD (1 time)
1995 Expression of EPSP/spike potentiation following low frequency and tetanic stimulation in the CA1 area of the rat hippocampus.
21  erythromycin-sulfisoxazole
(1 time)
Communicable Diseases
(1 time)
--- 1987 Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial.
22  ethanol-to-substrate
(1 time)
AERS (1 time)
DBP (1 time)
1991 Production of ethanol from straw and bamboo pulp by primary isolates of Clostridium thermocellum.
23  Ethanol-to-syrup
(1 time)
Carbohydrates
(1 time)
PCA (1 time)
2014 Fractionation of Eremurus spectabilis fructans by ethanol: Box-Behnken design and principal component analysis.
24  Ethanol/Steroid
(1 time)
Otolaryngology
(1 time)
AHI (1 time)
OSAS (1 time)
SEIM (1 time)
2005 ["Restricted ablation" of elongated uvula mucosa by the injection of the ethanol/steroid mixture: a new treatment for snoring and OSAS].
25  excretion/secretion products
(1 time)
Parasitology
(1 time)
--- 2002 Immunization with cathepsin L proteinases CL1 and CL2 secreted by Fasciola hepatica elicit a preferential type 1 response based on IgG2a antibodies in rats.
26  excretory-secretory antigens
(1 time)
NLX (1 time)
2019 A Survey on the Adjuvant Role of Naloxone Alone or Combined with Alum in Vaccination Against Fasciolosis in BALB/c Mice.
27  excretory/secretory components
(1 time)
Parasitology
(1 time)
--- 1997 Trichuris suis: thiol protease activity from adult worms.
28  exudate level/maximum serum level
(1 time)
Urology
(1 time)
--- 1985 [Studies on antibiotics distribution in the post-operative cavity].
29  ezetimibe/simvastatin fixed-dose combination
(1 time)
Lipoproteins
(1 time)
CHD (1 time)
LDL-C (1 time)
2010 Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients.